Increased ARG1 expression in epithelial ovarian cancer is associated with immune suppression and tumour growth, whereas ARG1 inhibition reduces ARG1‐mediated immune suppression and tumour progression [74]. The gene discussed is ARG1; the disease is neoplasm.